| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.026 | 0.7 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.7 |